Skip to main content
. 2021 Mar 11;12:636824. doi: 10.3389/fendo.2021.636824

Table 1.

Considerations in islet transplantation.

Allotransplantation Autotransplantation Stem cell transplantation
Patient Population Patients with type 1 diabetes and severe hypoglycemia, glycemic variability or microvascular complications Patients with chronic pancreatitis undergoing pancreatectomy Investigational; type 1 diabetes with potential application to other forms of diabetes
Source of Islet Material Cadaveric islets Autologous transplant Human pluripotent stem cells (induced pluripotent stem cells or embryonic stem cells)
Limitations - Immunosuppression required
- Limited supply of donors
- Limited cell mass, from one’s own diseased pancreas -Remains investigational
- Need to scale up to sufficient functional mass to reverse diabetes in humans